Reye syndrome - Insights on causation and prognosis

Archives of Disease in Childhood

Volumn 85, Issue 5, 2001, Pages 351-353

  Glasgow, J F T ^a,c   Middleton, B ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; CHEMICALLY INDUCED DISORDER; CHILD; HUMAN; METABOLISM; PROGNOSIS; REVIEW; REYE SYNDROME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; HUMANS; PROGNOSIS; REYE SYNDROME;

EID: 0035514033     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.85.5.351     Document Type: Article

References (27)

1. Wood C, ed. Reye's syndrome. Round Table Series 8. London: Royal Society of Medicine Services, 1988:1,80-3,16,45,64,25,135.153-4.
2. Hall SM, Lynn R. Reye syndrome. In: Guy M, Nicoll A, Lynn R, eds. British Paediatric Surveillance Unit, 12th Annual Report. London: RCPCH, 1998.
3. Casteels-Van Daele M. Reye syndrome or side-effects of anti-emetics? Eur J Pediatr 1991;150:456-9.
4. Orlowski JP. Whatever happened to Reye syndrome? Did it ever really exist? Crit Care Med 1999;27:1582-7.
5. Hall SM. Reye's syndrome and aspirin: a review. Br J Clin Pract 1990;44(suppl 70):4-11.
6. Forsyth BW, Horwitz RI, Acampora D, et al. New epidemiologic evidence confirming that bias does not explain the aspirin Reye's syndrome association. JAMA 1989;261:2517-24.
7. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999;340:1377-82.
8. Soumerai SB, Ross-Degnan D, Kahn JS. Effects of professional and media warnings about the association between aspirin use in children and Reye's syndrome. Milbank Quarterly 1992;70:155-82.
9. Hardie RM, Newton LH, Bruce JC, et al. The changing clinical pattern of Reye's syndrome 1982 1990. Arch Dis Child 1996;74:400-5.
10. Monto AS. The disappearance of Reye's syndrome - a public health triumph. N Engl J Med 1999;340:1423-4.
11. Meert KL, Kauffman RE, Deshmukh DR, Sarnaik AP. Impaired oxidative metabolism of salicylate in Reye's syndrome. Dev Pharmacol Ther 1990;15:57-60.
12. Herbein G, O'Brien WA. Tumor necrosis factor-alpha and TNF receptors. Proc Soc Exp Biol Med 2000;223:241-57.
13. Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenetic role of endotoxin in Reye's syndrome. Lancet 1975;1:1272-4.
14. Larrick JW, Kunkel SL. Is Reye's syndrome caused by augmented release of tumour necrosis factor? Lancet 1986;2:132-3.
15. Yin M-J, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit activity of IκB kinase-β Nature 1998;396:77-80.
16. Pessayre D, Mansouri A, Haouzi D, Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999;15:367-73.
17. Halestrap AP. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. In: Brown GC, Nicholls DG, Cooper CE, eds. Mitochondria and cell death. London: Portland Press, 1999:181-203.
18. Trost LC, Lemasters JJ. The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury. J Pharmacol Exp Ther 1996;278:1000-5.
19. Trost LC, Lemasters JJ. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. Toxicol Appl Pharmacol 1997;147:431-41.
20. Paumen M, Ishida Y, Muramatsu M, et al. Inhibition of carnitine palmitoyl-transferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 1997;272:3324-9.
21. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis Proc Natl Acad Sci USA 1998;95:681-6.
22. Glasgow JFT, Middleton B, Moore R, et al. The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls, Biochem Biophys Acta 1999;1454:115-25.
23. Maddaiah VT, Miller PS. Effects of ammonium chloride, salicylate, and carnitine on palmitic acid oxidation in rat liver slices. Pediatr Res 1989;25:19-23.
24. Ricquier D, Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 2000;345:161-79.
25. Boss O, Hagen T, Lowell BB. Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 2000;49:143-56.
26. Baron IS, Fennell EB, Voeller K. Pediatric neuropsychology in the medical setting. New York: Oxford University Press, 1995.
27. Meekin S, McCusker C, Glasgow JFT, Rooney N. A long-term follow-up of cognitive, emotional and behavioural sequelae to Reye's syndrome. Dev Med child Neurol 1999;41:549-53.